1. Home
  2. LGND vs GNL Comparison

LGND vs GNL Comparison

Compare LGND & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • GNL
  • Stock Information
  • Founded
  • LGND 1987
  • GNL 2011
  • Country
  • LGND United States
  • GNL United States
  • Employees
  • LGND N/A
  • GNL N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • GNL Real Estate Investment Trusts
  • Sector
  • LGND Health Care
  • GNL Real Estate
  • Exchange
  • LGND Nasdaq
  • GNL Nasdaq
  • Market Cap
  • LGND 2.0B
  • GNL 1.6B
  • IPO Year
  • LGND 1992
  • GNL N/A
  • Fundamental
  • Price
  • LGND $108.55
  • GNL $7.51
  • Analyst Decision
  • LGND Strong Buy
  • GNL Buy
  • Analyst Count
  • LGND 7
  • GNL 4
  • Target Price
  • LGND $144.67
  • GNL $9.50
  • AVG Volume (30 Days)
  • LGND 116.1K
  • GNL 2.3M
  • Earning Date
  • LGND 05-08-2025
  • GNL 05-07-2025
  • Dividend Yield
  • LGND N/A
  • GNL 13.55%
  • EPS Growth
  • LGND N/A
  • GNL N/A
  • EPS
  • LGND N/A
  • GNL N/A
  • Revenue
  • LGND $167,133,000.00
  • GNL $805,010,000.00
  • Revenue This Year
  • LGND $16.47
  • GNL N/A
  • Revenue Next Year
  • LGND $19.44
  • GNL N/A
  • P/E Ratio
  • LGND N/A
  • GNL N/A
  • Revenue Growth
  • LGND 27.28
  • GNL 56.29
  • 52 Week Low
  • LGND $69.17
  • GNL $6.51
  • 52 Week High
  • LGND $129.90
  • GNL $9.11
  • Technical
  • Relative Strength Index (RSI)
  • LGND 53.94
  • GNL 49.26
  • Support Level
  • LGND $101.24
  • GNL $7.48
  • Resistance Level
  • LGND $111.39
  • GNL $7.74
  • Average True Range (ATR)
  • LGND 5.67
  • GNL 0.31
  • MACD
  • LGND 0.82
  • GNL 0.03
  • Stochastic Oscillator
  • LGND 84.05
  • GNL 71.73

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: